Biomethylation is the major human metabolic pathway for inorganic arsenic,
and the speciation of arsenic metabolites is essential to a better understa
nding of arsenic metabolism and health effects. Here we describe a techniqu
e for the speciation of arsenic in human urine and demonstrate its applicat
ion to the discovery of key arsenic metabolic intermediates, monomethylarso
nous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), in human urine.
The study provides a direct evidence in support of the proposed arsenic met
hylation pathway in the human. The finding of MMA(III) and DMA(III) in huma
n urine, along with recent studies showing the high toxicity of these arsen
icals, suggests that the usual belief of arsenic detoxification by methylat
ion needs to be reconsidered, The arsenic speciation technique is based on
ion pair chromatographic separation of arsenic species on a 3-mum particle
size column at 50 degreesC followed by hydride generation atomic fluorescen
ce detection. Speciation of MMA(III), DMA(III), arsenite (As-III), arsenate
(As-V), monomethylarsonic acid(MMA(V)), and dimethylarsinic acid (DMA(V))
in urine samples is complete in 6 min with detection limits of 0.5-2 mug/L.
There is no need for any sample pretreatment. The capability of rapid anal
ysis of trace levels of arsenic species, which resulted in the findings of
the key metabolic intermediates, makes the technique useful for routine ars
enic speciation analysis required for toxicological and epidemiological stu
dies.